NCT00422955View on ClinicalTrials.gov

Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Neuropathy, Diabetic
Interventions
DRUG

rosiglitazone

Trial Locations (1)

6525 EZ

GSK Investigational Site, Nijmegen

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY